Health Condition 1: C900- Multiple myeloma
Conditions
Interventions
Intervention1: not applicable: not applicable
Control Intervention1: not applicable: not applicable
Sponsors
Advanced Centre for Training, Research and Education in Cancer
Eligibility
Inclusion criteria
Inclusion criteria: -Patients of Multiple myeloma who have undergone ASCT -Patients who have relapsed post ASCT
Exclusion criteria
Exclusion criteria: -Other plasma cell dyscrasias who undergo ASCT (like AL amyloidosis, POEMS syndrome etc)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Response rates with first salvage regimen in Multiple myeloma patients who relapse post ASCT - PFS-2 rates with different salvage regimens in Multiple myeloma Timepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| -Incidence of relapse or progression post ASCT -Time to relapse or progression post ASCT -PFS-1 post ASCT in standard versus high-risk Multiple myeloma -Overall Survival in Multiple Myeloma patients who relapse post ASCT -Median time to start of first salvage post ASCT -Median number of relapses or progression post ASCT -Median number of salvage therapies given post ASCTTimepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr Arti Goel
Tata Memorial Centre ACTREC (Advanced Centre for Treatment, Research and Education in Cancer)
Outcome results
None listed